cro.directory
← Compare landing

Ace Therapeutics vs VIRSCIO

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryAce TherapeuticsVIRSCIO
SummaryPreclinical CRO providing integrated research services including efficacy testing, disease model development, PK/PD, toxicology, biomarker research, and safety assessment across respiratory, ophthalmology, cardiovascular, and neurology therapeutic areas.Virscio is a preclinical CRO offering non-human primate studies, histopathology, and molecular biology services. It supports IND-enabling efficacy, safety, and PK/PD programs in CNS, ophthalmology, and cardiometabolic areas.
ServicesData not yet provided.
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • Specialized & Large-Animal Models
  • Clinical Imaging Core Lab
  • Regulatory Affairs
  • Translational Research
  • Pathology & Histology Services
ModalitiesData not yet provided.
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
Indications
  • Neurology
  • Psychiatry
  • Cardiovascular
  • Respiratory
  • Ophthalmology
  • Neurology
  • Metabolic
  • Cardiovascular
  • Ophthalmology
Phases
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
Sourcing modelsData not yet provided.Data not yet provided.
LocationsData not yet provided.
  • New Haven, New Haven, CT, United States
  • Headquarters, New Haven, CT, US
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Ace Therapeutics alternatives · VIRSCIO alternatives

Markdown mirror: /compare/ace-therapeutics/virscio.md